NM 102
Alternative Names: NM-102Latest Information Update: 21 Sep 2023
At a glance
- Originator Unknown
- Developer 9 Meters Biopharma; Gustave Roussy
- Class Antineoplastics; Peptides
- Mechanism of Action Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Gastrointestinal disorders